Prof. James Bashkin is a Professor of Chemistry and Bio-Chemistry at the University of Missouri, St.Louis. Prior to this, he was an NIH postdoctoral fellow at Harvard before joining Monsanto Corporate Research, which later became Pharmacia and then Pfizer. His recent research interest has been at the interface of chemistry and biology, in areas such as "chemical genomics," the design of antiviral and anticancer agents, and Green Chemistry.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Liran Carmel is a professor of computational biology at the Hebrew University of Jerusalem in Israel. Liran has won many awards, including the Michael Milken prize, the Farkash award, and the Eshkol fellowship. Liran is studying a host of topics in molecular evolution, RNA biology, and genetics and is particularly interested in human evolution and in understanding the very recent evolutionary adaptations that led to the development of human-specific traits. He is among the founders of paleo-epigenetics, a field of study where epigenetic signals are reconstructed in ancient genomes, thus allowing to obtain information on ancient gene activity patterns.

Hosted on Acast. See acast.com/privacy for more information.

Joel Peterson is the 12-year Chairman of JetBlue Airways, retiring in May 2020, former Chairman of The Hoover Institution, and the Founding Partner of Peterson Partners, a Salt Lake City-based investment management firm with $1B under management. Since 1992, Peterson has been on the faculty at the Graduate School of Business at Stanford University, teaching courses in real estate investment, entrepreneurship, and leadership.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Eleftherios Mylonakis is a Professor of Infectious Diseases at Brown University and the Chief of Infectious Diseases at Rhode Island and Miriam Hospitals. He is also the Director of the COBRE Center for Antimicrobial Resistance and Therapeutic Discovery. He is Assistant Dean for Outpatient Investigations and Director of the Center for Outpatient and Longitudinal Medical Research at the Alpert Medical School of Brown University and Professor of Molecular Microbiology and Immunology. He has 8 patents and almost 400 articles in peer-reviewed literature.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Brian Keating is a Professor of Physics at the Center for Astrophysics & Space Sciences at the University of California, San Diego. Prof. Keating's research area is the study of the cosmic microwave background and its relationship to the origin and evolution of the universe. In 2001 he conceived the first BICEP experiment (Background Imaging of Cosmic Extragalactic Polarization), located at the South Pole. Later he became Director of the Simons Observatory, co-located with the ACT telescopes in northern Chile. The project includes over 250 collaborators from over 30 institutions around the world.

Hosted on Acast. See acast.com/privacy for more information.

Prof Bart Selman is a Professor of Computer Science at Cornell University. He is the incoming President of the Association for the Advancement of Artificial Intelligence (AAAI), the main international professional society for AI researchers and practitioners. Last year, he co-chaired a national study to determine a 20-year Roadmap for AI research, to guide US government investments in AI research. Prof. Selman was previously at AT&T Bell Laboratories. He has authored numerous publications and has won many awards.

Hosted on Acast. See acast.com/privacy for more information.

Mr. Jim Jordan is the President of the Pittsburgh Life Sciences Greenhouse and the Managing Director of the Accelerator Funds. Jim has served as a Distinguished Service Professor of Healthcare & Biotechnology Management at Carnegie Mellon University. He has written two books; Innovation, Commercialization, and Start-ups in Life Sciences, The Intellectual Property Pyramid Assessment, and is currently working on his third book, Health Systems.

Hosted on Acast. See acast.com/privacy for more information.

Prof Anup Malani is a Professor at the University of Chicago Law School and a Professor at the Pritzker School of Medicine at the University of Chicago.  He is also a Research Associate at the National Bureau of Economic Research in Boston, a Senior Fellow at the Schaeffer Center at the University of Southern California, and an editor at the Journal of Law and Economics. Prof. Malani is the co-founder and Faculty Director of the International Innovation Corps, a social service program that sends teams of US and foreign university graduates to work on innovative development projects with government officials in India.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Steve Greenbaum is a Professor of Physics at Hunter College in the City University of New York and a Fellow of the American Physical Society. Prof. Greenbaum's main research interest involves spectroscopic studies of disordered solids by magnetic resonance and synchrotron x-ray absorption, most of which have recently centered on materials for electrochemical energy storage and conversion. He has authored or co-authored over 260 peer-reviewed publications and given over 60 invited talks at national or international conferences.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Kenneth Kaitin is a professor of Public Health and Medicine at Tufts School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in Shanghai, and a consultant to the U.S. Department of Defense on bioterror countermeasures. Ken’s research focuses on the economic, scientific, regulatory, and political factors that affect pharmaceutical development.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Robert Bird is a Professor of Business Law and the Chair in Business Ethics at the University of Connecticut. Robert's wide-ranging research focuses on corporate social responsibility, corporate compliance, employment law, legal strategy, and the intersection of law and business. His work has been published widely and he has received numerous teaching and research awards and is currently the President-Elect of the Academy of Legal Studies in Business.

Hosted on Acast. See acast.com/privacy for more information.

Prof. David Ikenberry was the Chair of Finance at the University of Illinois at Urbana-Champaign and the Associate Dean of the Executive programs. Later he served as the Dean of the Leeds School of Business at the University of Colorado, Boulder, and now serves as the full professor in the School. He was an early pioneer among researchers examining long-horizon stock returns, particularly returns subsequent to major corporate news events. Much of his work relates to behavioral finance and the extent to which news is incorporated into market prices. His most noted work has studied open market stock repurchase programs. Please excuse the slight overlap in the audio.

Hosted on Acast. See acast.com/privacy for more information.

Prof. George Perry is a Professor of Biology and Chemistry at The University of Texas at San Antonio. Prof Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.  Perry's research is primarily focused on how Alzheimer’s disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Richard Mammone, a professor of engineering and business at Rutgers University. He is a fellow of the National Academy of Inventors, recipient of the Thomas Edison Patent Award and inductee of the New Jersey Inventors Hall of Fame. He has published over 200 papers and has 30 patents. He was a founding editorial board member of the IEEE Neural Network Society and was the Associate Vice President of Innovation and Partnerships of Rutgers.

Hosted on Acast. See acast.com/privacy for more information.

Marion Nestle is a Professor of Nutrition, Food Studies, and Public Health, at New York University. She is also a Visiting Professor of Nutritional Sciences at Cornell. Her research and writing examine scientific and socioeconomic influences on food choice and its consequences, emphasizing the role of food industry marketing. She is the author of six prize-winning books. She has received many awards and honors for her excellent teaching, research, and writing.

Hosted on Acast. See acast.com/privacy for more information.

Dr. Stanley Litow is a Professor at Columbia and Duke University, and serve as Innovator in Residence at Duke. He is a speaker, writer and subject matter expert on Education and Corporate Social Responsibility and had a career in the public, private and not for profit sectors, including President of the IBM Foundation, Deputy Schools Chancellor for New York City, and Founder of Interface. He has served on several Presidential Commissions and currently serves as a Trustee of the State University of New York. He is also a columnist for Barron's.

Hosted on Acast. See acast.com/privacy for more information.

Professor Stephen Hinshaw is a Professor of Psychology at the University of California, Berkeley, and Professor of Psychiatry at UCSF.  His work focuses on developmental psychopathology, clinical interventions in attention deficits and hyperactivity, and mental illness stigma.  His excellent teaching and research over the years brought him numerous awards including those from the Society for Science of Clinical Psychology, the Society for Research in Child Development, and the American Psychological Association. He has authored over 360 articles and chapters plus 12 books

Hosted on Acast. See acast.com/privacy for more information.

Dr. Sara Abiola is an assistant professor of health policy & management at the Columbia Mailman School of Public Health and co-director of the Better Health Systems Lab that analyzes law, policy, and technological innovations designed to facilitate health systems strengthening and transformation through multisector collaboration and integration. She has constructed legal databases to map noncommunicable disease prevention policy and food policy at the global and national level and currently explores statutory and regulatory mechanisms to integrate the delivery of health and social services to address inequality and the social determinants of health.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Dr. Mehdi Anwar is a Professor of Electrical and Computer Engineering at the University of Connecticut. As a Jefferson Science Fellow, he served as Special Adviser for Technology Transfer and Innovation in the office of Intellectual Property Enforcement, Economic Bureau, U. S. Department of State. At present, Dr. Anwar is assisting U. S. Department of State and other U. S. Government organizations and the United Nations Office for the Least Developed Countries, Landlocked Developing Countries, and Small Island Developing States to stand up the newly established United Nations Technology Bank.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Bruce Mizrach is a professor in the Department of Economics at Rutgers University. He has held appointments at Boston College, the Wharton School, the Federal Reserve Bank of New York,  and NYU Stern School of business. Bruce is the founder and editor of Studies in Nonlinear Dynamics and Econometrics, which is devoted to using the nonlinear analysis to understand economic and financial markets. His most recent work is on the market microstructure of electronic limit order markets in bonds, equities, and commodity markets.

Hosted on Acast. See acast.com/privacy for more information.

Dr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.

Hosted on Acast. See acast.com/privacy for more information.

Jeffrey Townsend is the Elihu Professor of Biostatistics and Ecology and Evolutionary Biology at the Yale School of Public Health and Yale University. He is an experimentalist and a theoretician; someone who performed the first experiments to show how extensively genome-wide gene expression varies in one individual organism to another within a population; who has developed theory to reveal not just what is known, but what is unknown and unknowable in how organisms have descended from their ancestors; who has pioneered both experimental and theoretical approaches enabling us to understand the evolutionary changes that give an organism its form, function, and ability to survive and propagate. Currently, he spends the majority of his time working on evolutionary theory applied to tumor genome sequencing, revealing how cancer evolves from normal tissue to malignant tissue—how cancer evolves within us.

Hosted on Acast. See acast.com/privacy for more information.

Prof Warren Powell taught at Princeton for almost 40 years, where he was drawn to the opportunity of bringing advanced analytics to the trucking industry which introduced him to the challenge of making high-dimensional decisions (such as assigning drivers to loads) under uncertainty.  This problem guided a lifetime of research in stochastic optimization using approximate dynamic programming. His research produced over 250 papers and two books with the help of 60 graduate students and post-docs, supported by $50 million in research funding.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Julia Lane is a Professor at the New York University Wagner Graduate School of Public Service and an NYU Fellow for Innovation Analytics. She is a senior advisor in the Office of the Federal CIO at the White House, supporting the implementation of the Federal Data Strategy. She cofounded the Coleridge Initiative, whose goal is to use data to transform the way governments access and use data for the social good through training programs, research projects, and a secure data facility.

Hosted on Acast. See acast.com/privacy for more information.

Ian Williams was born in England in 1954. He trained as a biochemist at the Universities of Bristol and Oxford and received an MFA from Bennington College in Vermont. He worked for Pfizer for twenty years heading the Molecular Sciences Department and serving in the Research strategy group. He and his wife, Nancy Hutson, have a farm in Connecticut containing over 50 large-scale sculptures that Williams has made over the last decade. Together with Nancy, he has ridden in horseback safaris in many parts of the world. He may be reached at ian.inc@mac.com

Hosted on Acast. See acast.com/privacy for more information.

After obtaining his medical degree in Belgium in 1972, Pierre Etienne moved to McGill University, where he did postgraduate work in neurochemistry. There he directed a program on the biochemical, physiological, and neuropathological basis of Alzheimer's disease. After a brief passage in experimental medicine at Ciba-Geigy (now Novartis), he went back to McGill in 1987, dividing his time between the Montreal Neurological Institute and the Allan Memorial Institute. In 1989 he joined Pfizer as Director of Experimental Medicine, responsible for all Phase 2 A programs for US and Japan discovered compounds. In 2003, he became CEO of PhageTech, Inc., a privately-held biotechnology company based in Montreal, Canada. PhageTech exploited a proprietary platform based on phage-bacterial intracellular interactions to research and develop new classes of synthetic antibiotics. Phagetech later became Targanta Therapeutics that went public on NASDAQ (TARG) in the summer of 2008. In December 2009, he started a new life as a physician at the Douglas Institute. In July 2011, he was appointed Director of the Clinical Research Division. He is the co-Director of the Alzheimer’s disease prevention program (Stop-AD).

Hosted on Acast. See acast.com/privacy for more information.